Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
89bio, Inc. Common Stock
IPO Date: November 19, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $1.47B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.38 | 3.48%
Avg Daily Range (30 D): $0.27 | 3.11%
Avg Daily Range (90 D): $0.34 | 4.23%
Institutional Daily Volume
Avg Daily Volume: .81M
Avg Daily Volume (30 D): 1.97M
Avg Daily Volume (90 D): 1.68M
Trade Size
Avg Trade Size (Sh.): 97
Avg Trade Size (Sh.) (30 D): 96
Avg Trade Size (Sh.) (90 D): 88
Institutional Trades
Total Inst.Trades: 1,162
Avg Inst. Trade: $2.06M
Avg Inst. Trade (30 D): $2.01M
Avg Inst. Trade (90 D): $2.1M
Avg Inst. Trade Volume: .19M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.47M
Avg Closing Trade (30 D): $2.16M
Avg Closing Trade (90 D): $2.34M
Avg Closing Volume: 219.86K
   
News
Jan 9, 2025 @ 6:00 PM
Rare Endocrinology and Metabolic Disorders Market ...
Source: Delveinsight
Nov 29, 2024 @ 6:30 PM
89bio Announces Inducement Grants Under Nasdaq Lis...
Source: N/A
Nov 13, 2024 @ 4:58 AM
89bio, Inc. Announces Upsized Pricing of $125.0 Mi...
Source: 89Bio, Inc.
Jun 14, 2024 @ 8:05 PM
89bio Announces Inducement Grants Under Nasdaq Lis...
Source: 89bio, Inc.
May 22, 2024 @ 8:05 PM
89bio to Present 48-Week Data from ENLIVEN Phase 2...
Source: 89bio, Inc.
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $-.49 $-1.39
Diluted EPS $-.49 $-1.39
Revenue $ $ M $ M
Gross Profit $ $ $
Net Income / Loss $ $ -71.28M $ -149.07M
Operating Income / Loss $ $ -75.91M $ -151.94M
Cost of Revenue $ $ $
Net Cash Flow $ $ 189.34M $ -120.81M
PE Ratio